Tachyarrhythmias following coronary artery bypass graft surgery: Epidemiology, mechanisms, and current therapeutic strategies

Thoracic and Cardiovascular Surgeon

Volumn 45, Issue 5, 1997, Pages 232-237

  Willems, St ^a   Weiss, Ch ^a   Meinertz, Th ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIGOXIN; FLECAINIDE; LIDOCAINE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030670045     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013733     Document Type: Article

References (46)

1. Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis. 1989;31: 367-78.
2. Pires LA, Wagshal AB, Lancey R, Huang SKS. Arrhythmias and conduction disturbances after coronary artery bypass graft surgery: epidemiology, management, and prognosis. Am Heart J. 1995; 129: 799-808.
3. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 1996;94: 390-7.
4. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes and resource utilization. JAMA 1996;276: 300-6.
5. Waldo AL. Atrial fibrillation following open heart surgery: mechanism and treatment. In: Olssen SB, Allessie MA, Campbell RWF, eds. Atrial fibrillation: mechanism and therapeutic strategies. Armonk, NY: Futura Publishing Comp; 1994:92-9.
6. Waldo AL, Cooper BC. Spontaneous onset of type I atrial flutter in patients. J Am Coll Cardiol. 1996;28: 707-12.
7. Fuller JA, Adams GC, Buxton B. Atrial fibrillation after coronary artery bypass grafting: is it a disease of elderly? J. Thorac Cardiovasc Surg. 1989;97: 821-5.
8. Salazar C, Frishman W, Friedman S, et al. Beta-blockade therapy for supraventricular tachyarrhythmias after coronary artery surgery: a propranolol withdrawal syndrome? Angiology. 1979;30: 816-9.
9. White HD, Antman GM, Glynn MA, et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary bypass surgery. Circulation. 1984;70: 479-84.
10. Boudalas H, Snyder GL, Lewis RP, Kates RE, Karayannacos PE, Vasko JS. Safety and rationale for continuation of propranolol therapy during coronary bypass operation. Ann Thorac Surg. 1978;26: 222-9.
11. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56: 539-49.
12. Silverman NA, Wright R, Levitsky S. Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Ann Surg. 1982; 196: 1994-7.
13. Pichelmaier AM, Harringer W, Haverich A, Lang V, Bolz A, Schaldach M. Prediction of the onset of atrial fibrillation after cardiac surgery using the monophasic action potential. Progr Biomed Res. 1966;12: 60-5.
14. Mc Allister HF, Luke RA, Whitlock RM, Smith WM. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. J Thorac Surg. 1993;56: 539-49.
15. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. Circulation. 1990;82: 1106-16.
16. Kowey PR, Levine JH, Herre JM, et al. Randomized, double-blind comparision of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation. 1995;11: 3255-63.
17. Scheinman MM, Levine JH, Cannom DS, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation. 1995;92: 3264-72.
18. Lynn GM, Stefano K, Reed JF III, Gee W, Nicholas G. Risk factor for stroke after coronary artery bypass. J Thorac Cardiovasc Surg. 1992;104: 1518-23.
19. Taylor GJ, Malik SA, Colliver JA, et al. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. Am J Cardiol. 1987;60: 905-7.
20. Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol. 1992;69: 963-5.
21. Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. Circulation. 1991; 84:III-236-43.
22. Graboys TB, Lown B, Podrid PJ, De Sliver R. Long-term survival of patients with malignant ventricular arrhythmias treated with antiarrhythmic drugs. Am J. Cardiol. 1982;50: 438-43.
23. Janse MJ, Opthof T. Mechanisms of ischemia induced arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology-from cell to bedside. Philadelphia: WB Saunders; 1995:489-95.
24. Hohnloser SH, Meinertz T, Dammbacher T, et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a propective, placebo-controlled study. Am Heart J. 1991;121: 89-95.
25. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors. Am Heart J. 1994;127: 1139-44.
26. Smith RC, Leung JM, Keith FM, Merrick S, Mangano DT. Ventricular dysrhythmias in patients undergoing coronary artery bypass graft surgery: incidence, characteristics, and prognostic importance. Am Heart J. 1992;123: 73-81.
27. Rubin DA, Nieminski KE, Monteferrante JC, Magee T, Reed GE, Herman MV. Ventricular arrhythmias after coronary artery bypass surgery: incidence, risk factors, and long-term prognosis. J Am Coll Cardiol. 1985;6: 307-10.
28. Kron IL, DiMarco JP, Harman PK, et al. Unanticipated postoperative ventricular tachyarrhythmias. Ann Thorac Surg. 1984;38: 317-22.
29. Sapin PM, Woelfel AK, Foster JR. Unexpected ventricular tachyarrhythmias soon after cardiac surgery. Am J Cardiol. 1991;68: 1099-100.
30. Tam SKC, Miller JM, Edmunds LH Jr. Unexpected, sustained ventricular tachyarrhythmias after cardiac operations. J Thorac Cardiovasc Surg. 1991;102: 883-9.
31. Topol EJ, Lerman BB, Baughman KL, Platia EV, Griffith LSC. De novo refractory ventricular tachyarrhythmias after coronary revascularization. Am J Cardiol. 1986;57: 59-62.
32. Smith RC, Leung JM, Mangano DT, and the SPI Research Group. Postoperative myocardial ischemia in patients undergoing coronary artery bypass graft surgery. Anesthesiology. 1991;74: 464-73.
33. Yurvati AHO, Sanders SP, Dullye LJ, Carney MP, Archer RL, Koro PP. Antiarrhythmic response to intravenously administered magnesium after cardiac surgery. Southern Medical Journal. 1992;85: 714-7.
34. Pires LA, Huang SKS. Non-sustained ventricular tachycardia: identification and management of high-risk patients. Am Heart J. 1993;126: 189-200.
35. Burkart F, Pfisterer M, Kiowski W, Follath F, Burkhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias. J Am Coll Cardiol. 1990;16: 1711-18.
36. Cairns JA, Conolly SJ, Robers R, Gent M. Randomised trial of outcome after myocardial in farction in patients with frequent or repetetive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349:675-82
37. Julian DG, Camm AJ, Frangiubetol. Randomised trial of effect of amiodarone ou mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Laucet 1997; 349:667-74.
38. Echt DS, Liebson PR, Mitchell LB. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med. 1991;324: 781-8.
39. Klein H, Trappe HJ, Fieguth HG, Nissan S. Prospective studies evaluating prophylactic therapy for high risk patients with coronary artery disease. Pace. 1993; 16(3), Part II: 564-70.
40. Block M, Breithardt G. Long-term follow-up and clinical results of implantable cardioverter defibrillators. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology-from cell to bedside. Philadelphia: WB Saunders; 1995; pp 1412-25.
41. Callans DJ, Josephson ME. Ventricular tachycardia in the setting of coronary artery disease. In Zipes DP, Jalife J, eds. Cardiac electrophysiology-from cell to bedside. Philadelphia: WB Saunders; 1995:732-43.
42. Callans DJ, Marchlinski FE. Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms. J Am Coll Cardiol. 1992;19: 111-7.
43. Cobb LA, Baum RS, Alvarez H. Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up. Circulation. 1975;52: 223-9.
44. Echt DS, Amstron K, Schmidt P, Oyer PE, Stinson EB, Winkle RA. Clinical experience, complications, and survival in 70 patients with the automatic cardioverter/defibrilator. Circulation. 1985; 71: 289-96.
45. Mirowski M, Reid PR, Winkle RA, et al. Mortality in patients with implanted automatic defibrillation. Ann Intern Med. 1983;98: 585-8.
46. Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. Br Heart J. 1993;70: 56-60.